GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RH Bophelo Ltd (JSE:RHB) » Definitions » EV-to-EBITDA

RH Bophelo (JSE:RHB) EV-to-EBITDA : -29.75 (As of May. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is RH Bophelo EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, RH Bophelo's enterprise value is R201.38 Mil. RH Bophelo's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 was R-6.77 Mil. Therefore, RH Bophelo's EV-to-EBITDA for today is -29.75.

The historical rank and industry rank for RH Bophelo's EV-to-EBITDA or its related term are showing as below:

JSE:RHB' s EV-to-EBITDA Range Over the Past 10 Years
Min: -38.71   Med: 2   Max: 63.36
Current: -29.75

During the past 7 years, the highest EV-to-EBITDA of RH Bophelo was 63.36. The lowest was -38.71. And the median was 2.00.

JSE:RHB's EV-to-EBITDA is ranked worse than
100% of 460 companies
in the Healthcare Providers & Services industry
Industry Median: 13.06 vs JSE:RHB: -29.75

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), RH Bophelo's stock price is R3.20. RH Bophelo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was R-0.295. Therefore, RH Bophelo's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


RH Bophelo EV-to-EBITDA Historical Data

The historical data trend for RH Bophelo's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RH Bophelo EV-to-EBITDA Chart

RH Bophelo Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
EV-to-EBITDA
Get a 7-Day Free Trial 7.60 66.86 2.91 4.95 -5.78

RH Bophelo Semi-Annual Data
Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.95 - -5.78 -

Competitive Comparison of RH Bophelo's EV-to-EBITDA

For the Medical Care Facilities subindustry, RH Bophelo's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RH Bophelo's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RH Bophelo's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where RH Bophelo's EV-to-EBITDA falls into.



RH Bophelo EV-to-EBITDA Calculation

RH Bophelo's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=201.383/-6.769
=-29.75

RH Bophelo's current Enterprise Value is R201.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. RH Bophelo's EBITDA for the trailing twelve months (TTM) ended in Aug. 2023 was R-6.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RH Bophelo  (JSE:RHB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

RH Bophelo's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.20/-0.295
=At Loss

RH Bophelo's share price for today is R3.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. RH Bophelo's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2023 was R-0.295.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


RH Bophelo EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of RH Bophelo's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


RH Bophelo (JSE:RHB) Business Description

Traded in Other Exchanges
N/A
Address
Unit 12, 1st Floor, 1 Melrose Boulevard, Melrose Arch, Boulevard, Johannesburg, GT, ZAF, 2191
RH Bophelo Ltd is a healthcare investment company. Its main business involves the acquisition of healthcare assets in commercial entities or special situations across the South African market. It is engaged in making equity, quasi-equity, and equity-related investments in healthcare and financial services. The company invests in operational infrastructure, including health insurance, private hospital-related infrastructure, pharmaceuticals, retail, and distributions, in South Africa. Its segments are the Healthcare segment and Financial services segment.

RH Bophelo (JSE:RHB) Headlines

No Headlines